Ftse Mib
34.160,97
1,25%
DAX
19.984,32
0,74%
S&P 500
5.970,84
-1,11%
NASDAQ
19.722,03
-1,49%
Bitcoin
94.983,97
0,87%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Ligand Pharmaceuticals Incorporated (LGND) Ligand Pharmaceuticals Incorporated (LGND) Notizie

Ligand Pharmaceuticals Incorporated

LGND
109,19
-5,06 (-4,43%)
28 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/12/202415:00BWLigand Hosts 2024 Investor and Analyst Day and Introduces..
07/12/202401:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202402:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202422:44EDGAR2Form 144 - Report of proposed sale of securities
14/11/202421:19EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202414:00BWLigand to Present at Stifel 2024 Healthcare Conference
12/11/202416:25EDGAR2Form 144 - Report of proposed sale of securities
08/11/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
17/10/202413:30GLOBEPalvella Therapeutics Appoints Matthew E. Korenberg as Chief..
26/9/202402:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/9/202401:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/9/202401:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202423:30EDGAR2Form 144 - Report of proposed sale of securities
23/9/202423:27EDGAR2Form 144 - Report of proposed sale of securities
31/8/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202402:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202422:39EDGAR2Form 144 - Report of proposed sale of securities
27/8/202402:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202400:05EDGAR2Form 144 - Report of proposed sale of securities
13/8/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202423:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202423:16EDGAR2Form 144 - Report of proposed sale of securities
07/8/202422:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202423:15EDGAR2Form 8-K - Current report
17/7/202423:10EDGAR2Form 8-K - Current report
10/7/202422:02EDGAR2Form 8-K - Current report
09/7/202422:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/7/202413:38EDGAR2Form 8-K - Current report
01/7/202414:00GLOBELifecore Biomedical Announces Cooperation Agreement with..
03/6/202422:03EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
30/5/202422:03EDGAR2Form 8-K - Current report
18/5/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202423:45EDGAR2Form 144 - Report of proposed sale of securities
16/5/202423:39EDGAR2Form 144 - Report of proposed sale of securities
16/5/202401:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202400:01EDGAR2Form 144 - Report of proposed sale of securities
15/5/202420:45EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
15/5/202401:42EDGAR2Form 144 - Report of proposed sale of securities
09/5/202422:11EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/3/202419:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202400:12EDGAR2Form 144 - Report of proposed sale of securities
01/3/202422:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
01/3/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202400:05EDGAR2Form 144 - Report of proposed sale of securities
28/2/202423:43EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 112,05 Min: 108,19 Max: 113,125
Chiusura: 114,25

La tua Cronologia

NASDAQ
LGND
Ligand Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network